TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2009: $859.14M2010: $1.22B2011: $1.24B2012: $1.52B2013: $962.64M2014: $1.24B2015: $1.40B2016: $1.56B2017: $1.50B2018: $1.81B2019: $2.23B2020: $3.06B2021: $3.33B2022: $4.24B2023: $5.15B2024: $6.12B2025: $6.98B$6.98B
2009Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$6.98B+13.9%
2024$6.12B+18.9%
2023$5.15B+21.5%
2022$4.24B+27.2%
2021$3.33B+8.7%
2020$3.06B+37.2%
2019$2.23B+23.3%
2018$1.81B+20.4%
2017$1.50B-3.5%
2016$1.56B+10.9%
2015$1.40B+13.4%
2014$1.24B+28.7%
2013$962.64M-36.9%
2012$1.52B+23.1%
2011$1.24B+1.4%
2010$1.22B+42.2%
2009$859.14M—